Trademark Search in Canada

EXTENTRAK

View On IC.GC.CA

REGISTERED

on 7 Nov 2019

Last Applicant/ Owned by

BAYER AKTIENGESELLSCHAFT

Kaiser-Whilhelm-Allee51373 Leverkusen

Serial Number

1861213 filed on 5^th Oct 2017

Registration Number

TMA1062379 registered on 7^th Nov 2019

Registration expiry Date

7^th Nov 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

EXTENTRAK

Trademark usage description

pharmaceutical preparations for the treatment of cancer, autoimmune disease and for the treatment of inflammatory diseases namely inflammatory bowel d Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune disease and for the treatment of inflammatory diseases namely inflammatory bowel diseases and inflammatory connective tissue diseases; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and for the treatment of inflammatory diseases namely inflammatory bowel diseases and inflammatory connective tissue diseases; full line of pharmaceutical preparations for cancer, autoimmune disease and for the treatment of inflammatory diseases namely inflammatory bowel diseases and inflammatory connective tissue diseases

Classification kind code

Mark Details

Serial Number

1861213

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 25^th Sept 2019	Registration Pending
Submitted for opposition 191 on 25^th Sept 2019	Registration Fee Notice Sent
Submitted for opposition 42 on 3^rd Jul 2019	Advertised
Submitted for opposition 26 on 13^th Jun 2019	Approved
Submitted for opposition 27 on 24^th Apr 2019	Approval Notice Sent
Submitted for opposition 22 on 2^th Nov 2018	Search Recorded
Submitted for opposition 20 on 2^th Nov 2018	Examiner's First Report
Submitted for opposition 1 on 6^th Oct 2017	Created
Submitted for opposition 31 on 6^th Oct 2017	Formalized
Submitted for opposition 30 on 5^th Oct 2017	Filed